V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215890 | 20081934 | null | 71.4 | Curative (C) | null | 2020-01-03 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100065434 |
| 20215891 | 20081935 | null | 48 | Palliative (P) | null | 2019-04-29 | null | null | N | LENVATINIB | 100810727 |
| 20215897 | 20081941 | null | null | null | 2019-02-11 | 2019-02-14 | ECarboX | 02 | null | HCX | 101406178 |
| 20215900 | 20081943 | null | null | null | 2018-06-14 | 2018-06-15 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 101000078 |
| 20215902 | 20081944 | 1.65 | 80 | Palliative (P) | 2019-05-19 | 2019-05-20 | null | null | N | CAPECITABINE + IRINOTECAN | 100482520 |
| 20215907 | 20081947 | null | null | null | null | 2017-08-24 | null | null | null | HCX | 100143354 |
| 20215908 | 20081948 | 1.8 | 107 | Palliative (P) | 2020-03-07 | 2020-04-01 | null | null | N | HCX | 101653549 |
| 20215910 | 20081950 | 1.58 | 82.8 | Neo-adjuvant (N) | null | 2018-04-14 | null | null | N | HCX | 100171054 |
| 20215911 | 20081951 | 1.65 | 88.3 | Palliative (P) | null | 2017-12-25 | null | null | null | CISPLATIN + ETOPOSIDE | 101455004 |
| 20215912 | 20081952 | 1.69 | 67.7 | Palliative (P) | null | 2016-12-13 | null | null | N | HCX | 101240216 |
| 20215913 | 20081953 | 1.65 | 74 | Palliative (P) | 2018-07-12 | 2018-07-12 | null | null | N | CAPECITABINE + IRINOTECAN | 101651436 |
| 20215915 | 20081954 | 1.68 | 83.4 | Palliative (P) | 2019-01-26 | 2019-02-05 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100053632 |
| 20215916 | 20081955 | 1.7 | 94 | Disease modification (D) | 2016-12-21 | 2016-12-21 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101592243 |
| 20215917 | 20081956 | 1.71 | 100 | Palliative (P) | null | 2018-12-21 | null | null | N | LENVATINIB | 101225445 |
| 20215918 | 20081957 | 0 | 92 | Palliative (P) | null | 2017-06-10 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 100001693 |
| 20215919 | 20081958 | 1.75 | 100.7 | Neo-adjuvant (N) | 2018-11-22 | 2018-12-03 | ECF | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101347320 |
| 20215925 | 20081961 | null | null | null | 2019-11-22 | 2019-11-24 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101623710 |
| 20215926 | 20081962 | null | null | null | 2019-07-17 | 2019-08-10 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101099387 |
| 20215929 | 20081964 | 1.78 | 0 | Palliative (P) | null | 2019-10-11 | null | null | null | CISPLATIN + ETOPOSIDE | 100912525 |
| 20215934 | 20081969 | 1.82 | 83.4 | null | 2017-07-18 | 2017-07-26 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 101242766 |
| 20215935 | 20081970 | null | null | null | 2019-05-07 | 2019-05-07 | null | null | null | CAPECITABINE + IRINOTECAN | 100574773 |
| 20215936 | 20081971 | 1.82 | 67 | Palliative (P) | null | 2018-10-13 | null | null | Y | CETUXIMAB + IRINOTECAN + MDG | 101630201 |
| 20215938 | 20081972 | 1.7 | 75.9 | null | 2018-08-11 | 2018-08-13 | null | null | Y | CAPECITABINE + IRINOTECAN | 100318552 |
| 20215940 | 20081974 | null | null | null | null | 2017-01-16 | null | null | null | CAPECITABINE + IRINOTECAN | 100027577 |
| 20215941 | 20081975 | 1.62 | 59 | Neo-adjuvant (N) | null | 2018-07-21 | null | null | null | HCX | 101013570 |
| 20215943 | 20081976 | 1.57 | 107.6 | Neo-adjuvant (N) | 2018-09-01 | 2018-09-17 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + IRINOTECAN | 101049715 |
| 20215944 | 20081977 | 1.61 | 0 | Palliative (P) | null | 2016-08-29 | null | null | N | CAPECITABINE + IRINOTECAN | 101160748 |
| 20215945 | 20081978 | null | 139.8 | Palliative (P) | 2017-09-14 | 2017-09-17 | Cisplatin + Etoposide (3 day) | 02 | N | CISPLATIN + ETOPOSIDE | 100575979 |
| 20215946 | 20081979 | null | null | null | 2019-04-16 | 2019-04-29 | null | null | null | CISPLATIN + ETOPOSIDE | 100251317 |
| 20215948 | 20081980 | null | null | null | null | 2018-01-01 | null | null | null | CISPLATIN + ETOPOSIDE | 101220225 |
| 20215951 | 20081982 | 1.73 | 112 | Curative (C) | 2018-08-28 | 2018-09-03 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | N | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100733026 |
| 20215952 | 20081983 | 1.6 | 84 | Curative (C) | 2019-04-15 | 2019-04-17 | null | null | N | CAPECITABINE + MITOMYCIN + RT | 100815456 |
| 20215953 | 20081984 | null | null | null | null | 2017-05-01 | null | null | null | CISPLATIN + ETOPOSIDE | 100385585 |
| 20215954 | 20081985 | 1.6 | 76.2 | null | null | 2017-02-18 | null | null | Y | CAPECITABINE + IRINOTECAN | 100521003 |
| 20215955 | 20081986 | 1.8 | 132.25 | Palliative (P) | 2019-01-01 | 2019-01-19 | CISPLATIN + ETOPOSIDE | 02 | N | CISPLATIN + ETOPOSIDE | 100232685 |
| 20215957 | 20081988 | 1.81 | 86 | Neo-adjuvant (N) | null | 2017-06-18 | ECF | 2 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 101833818 |
| 20215958 | 20081989 | null | null | null | 2017-05-28 | 2017-05-28 | LENVATINIB | 02 | null | LENVATINIB | 101646940 |
| 20215960 | 20081990 | null | null | null | null | 2019-11-04 | null | null | null | LENVATINIB | 100755438 |
| 20215963 | 20081993 | null | null | null | null | 2020-02-20 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 100249536 |
| 20215964 | 20081994 | 1.77 | 78 | Palliative (P) | 2018-06-06 | 2018-06-06 | null | null | null | CETUXIMAB + IRINOTECAN + MDG | 101687247 |
| 20215965 | 20081995 | null | 52.1 | Palliative (P) | 2019-06-27 | 2019-06-27 | null | null | N | CETUXIMAB + IRINOTECAN + MDG | 101788530 |
| 20215966 | 20081996 | null | null | null | 2019-06-02 | 2019-07-05 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 100208596 |
| 20215968 | 20081998 | null | null | null | 2017-08-10 | 2017-08-10 | CISPLATIN + ETOPOSIDE | 02 | null | CISPLATIN + ETOPOSIDE | 101549047 |
| 20215969 | 20081999 | 1.75 | 83.6 | Palliative (P) | 2020-01-04 | 2020-01-08 | LENVATINIB | 02 | null | LENVATINIB | 101414721 |
| 20215974 | 20082003 | null | null | null | null | 2018-08-26 | null | null | null | HCX | 101771027 |
| 20215977 | 20082005 | 1.69 | 73 | Palliative (P) | 2017-12-19 | 2017-12-24 | Cape+Cisplatin+Trastuzumab Load | 2 | N | HCX | 100804767 |
| 20215979 | 20082007 | 1.67 | 92.7 | Neo-adjuvant (N) | 2019-02-09 | 2019-02-09 | Cetuximab + FOLFIRI cycle 2 onwards | N | null | CETUXIMAB + IRINOTECAN + MDG | 100155091 |
| 20215980 | 20082008 | 1.7 | 71 | Curative (C) | 2016-07-07 | 2016-07-23 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100911423 |
| 20215981 | 20082009 | 1.86 | 60 | Palliative (P) | 2018-09-26 | 2018-10-11 | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 02 | N | CAPECITABINE + CARBOPLATIN + EPIRUBICIN | 101531816 |
| 20215982 | 20082010 | null | null | null | null | 2020-10-03 | null | null | null | CAPECITABINE + IRINOTECAN | 100579426 |